| |
Control group n = 15 |
Obese groupn = 30 |
MS Groupn = 20 |
P |
| M |
SD |
M |
SD |
M |
SD |
| FBG (mg/dl) |
87.9 |
11.0 |
127.1 |
11.3 |
142.8 |
15.1 |
< 0.0001 |
| PP BG (mg/dl) |
124.7 |
8.7 |
153.2 |
13.3 |
201.9 |
16.7 |
< 0.0001 |
| HbA 1c (%) |
5.7 |
0.5 |
6.9 |
0.7 |
7.9 |
0.7 |
< 0.0001 |
| HOMA-IR |
0.48 |
0.1 |
0.58 |
0.1 |
0.73 |
0.4 |
0.0073* |
| Significance only between control and metabolic group |
| HOMA-β |
105.1 |
35.7 |
139.7 |
50.1 |
158.8 |
33.4 |
0.002* |
| No significant difference between obese and MS group |
| Cholesterol (mg/dl) |
153.4 |
33.4 |
187 |
41.3 |
200.9 |
29.5 |
0.0046* |
| No significant difference between obese and MS group |
| TG (mg/dl) |
117.7 |
33.1 |
141.1 |
37.2 |
169.6 |
22.3 |
< 0.0001 |
| No significant difference between obese and obese group |
| LDL - C (mg/dl) |
83.1 |
10.2 |
102.6 |
10.3 |
145.2 |
20.9 |
< 0.0001 |
| HDL - C (mg/dl) |
46.5 |
5.1 |
36.8 |
4.6 |
35.5 |
4.3 |
< 0.0001 |
| No significant difference between obese and MS group |
P values ˂ 0.05 were considered significant.